Achieve Life (ACHV) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ACHV Achieve Life

Watchlist

3.690
-0.130-3.40%

Close Dec 20 16:00 ET

3.770
+0.080+2.17%

Post 20:01 ET

126.90MMarket Cap-3.29P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
ReutersDec 9 08:30 ET
Press Release: Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
Dow JonesDec 9 08:30 ET
Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
TipRanksDec 5 10:22 ET · Ratings
Achieve Life To Advance Cytisinicline Into Phase 3 Study For Vaping Cessation In Q3, 2025
RTTNewsDec 3 10:15 ET
Achieve Life Sciences Announces Outcome of End-of-Phase 2 Meeting With FDA
TipRanksDec 3 08:40 ET
Express News | Achieve Life Sciences Inc - Expects to File Nda for Smoking Cessation in Q2 2025
ReutersDec 3 08:31 ET

Comments

MindOverMatter

Aug 13 19:03

$Achieve Life (ACHV.US)$

Jaguar8

May 29 07:01

NEWS

$Achieve Life (ACHV.US)$
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
Achieve Life Sciences has initiated the ORCA-OL clinical trial to evaluate the long-term safety of cytisinicline, a treatment for smoking and nicotine dependence. The open-label trial involves 29 U.S. sites and aims to collect data required for a New Drug Application (NDA) submission expected in the first ...

Jaguar8

May 6 11:33

$Achieve Life (ACHV.US)$
NEWS
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

Meltyy

Mar 20 10:18

Biotech Stock News 3/20

$Annovis Bio (ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...

Moo Top

Dec 12, 2023 10:22

Is this truly the bottom?

$Achieve Life (ACHV.US)$

Heat List

Overall

No Data